A new monograph on the NovaSure® system
View in browser
The only thing better than good data, is good data AND experience
When you decide on global endometrial ablation (GEA) for your patients, you have options. To provide a clinical and personal perspective, Hologic asked seven recognized experts to report on their choice of GEA modalities in a new monograph. Get their reviews of the latest literature plus real-world experiences from their practices.
Find out why physicians trust the NovaSure system as their treatment modality of choice for AUB
Based on published long-term data and my personal experience, I believe the NovaSure® endometrial ablation device has the most extensive track record of safety and continue to use it routinely in my practice.
  Dr. Cindy Basinski, MD, FACOG, FPMRS
  Newburgh, IN
Hear more from your peers at NovaSureMonograph.com
NovaSure® endometrial ablation is for premenopausal women with heavy periods due to benign causes who are finished childbearing. Pregnancy following the NovaSure procedure can be dangerous. The NovaSure procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. NovaSure endometrial ablation is not a sterilization procedure. Rare but serious risks include, but are not limited to, thermal injury, perforation and infection. Temporary side effects may include cramping, nausea, vomiting, discharge and spotting. Inform patients to contact you if they experience a possible side effect related to use of this product. For detailed benefit and risk information, please consult the IFU.
Hologic Logo
Hologic, NovaSure, The Science of Sure, and associated logos are trademarks or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.

EMB-00932-001 ©2017 Hologic, Inc.

This email was sent by: Hologic, Inc. 250 Campus Drive, Marlborough, MA 01752